GreenArt personal page - To The Moon

GreenArt

GreenArt

No personal profile

32Follow

5Followers

1Topic

0Badge

01-17

Hope to see V recovery next week. 😆

2025-12-31

$Ondas Holdings Inc.(ONDS)$ Take profits for new year meal.

2025-12-31

$Taiwan Semiconductor Manufacturing(TSM)$ profiting from volatility

2025-12-02

$Ondas Holdings Inc.(ONDS)$ Sold partial. Brought back after it pulled back again. Waiting for next trade.

2021-06-26

Kindly comment & like. Thank you!

Sorry, the original content has been removed

02-04 23:22

Monitoring for scooping.

@HRHRHRHR:$Microsoft(MSFT)$ $416 now... back to Year 2024 prices.. Imagine holding this stock till Jan 2026 and getting nothing in return 😅 So tempted to add MFST but gut feeling says geopolitics will cause the stock to fall much lower.

01-11

Add to long...

@Barcode:$Tesla Motors(TSLA)$ $NVIDIA(NVDA)$ $Intel(INTC)$ 09Jan26 ET 🇺🇸 | 10Jan26 NZT 🇳🇿 🚀 $TSLA +$10 now ⏪ Was -$8 vs pre-market earlier ⬆️ Now +$16 off the lows 📆 We’re sitting +$5 on the week — even though $NVDA’s AI autonomy stack was supposed to lead first — even though robotaxi fleets still run with safety drivers and L4 constraints — even though Elon Musk's political noise on X keeps feeding headline volatility 📈 Price before narratives. Always. 🗓️ Key dates now on the radar • 13 Jan hearing on lifting the 2,500 AV cap • 14 Jan Supreme Court opinion on Trump tariffs ⚡ Next week is shaping up volatile for $TSLA 🤖🦾🔋 🚘🤖 ʜᴀᴘᴘʏ TESLA ᴛʀᴀᴅɪɴɢ

2025-10-29

Brilliant move by NVDA CEO, investing into multiple & different "supply chain" from Intel to Nokia etc. The whole eco system intertwined and grow together, securing from fab to end user. Mitigating potential loss/risk in China market too. I will vote him CEO of the year of there's one. 😆

2025-10-28

I am using my gmail, google search, my cloud storage, Microsoft office. So, Google & Microsoft is my bet to go up. 🚀

2021-06-28

? ?Like & comment.

The Hong Kong Stock Exchange will resume trading at 1:30 p.m., as the rainstorm signal changes.

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3581654847570147","uuid":"3581654847570147","gmtCreate":1618820525876,"gmtModify":1624505397163,"name":"GreenArt","pinyin":"greenart","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/4da854bffe68ea665dbcd4c6e26e6e53","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":5,"headSize":32,"tweetSize":0,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":1,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.01.21","exceedPercentage":"80.65%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.10.11","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.05.29","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.05.09","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":12,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":14,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":529188267828240,"gmtCreate":1770218533034,"gmtModify":1770218538260,"author":{"id":"3581654847570147","authorId":"3581654847570147","name":"GreenArt","avatar":"https://static.tigerbbs.com/4da854bffe68ea665dbcd4c6e26e6e53","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581654847570147","idStr":"3581654847570147"},"themes":[],"title":"","htmlText":"Monitoring for scooping.&nbsp;","listText":"Monitoring for scooping.&nbsp;","text":"Monitoring for scooping.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/529188267828240","repostId":"528823073592016","repostType":1,"repost":{"id":528823073592016,"gmtCreate":1770129362432,"gmtModify":1770129494610,"author":{"id":"4125545119825582","authorId":"4125545119825582","name":"HRHRHRHR","avatar":"https://community-static.tradeup.com/news/f72f7c8c7a3f167c0f03f6041d1ff44f","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4125545119825582","idStr":"4125545119825582"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/MSFT\">$Microsoft(MSFT)$&nbsp;</a> $416 now... back to Year 2024 prices.. Imagine holding this stock till Jan 2026 and getting nothing in return 😅 So tempted to add MFST but gut feeling says geopolitics will cause the stock to fall much lower.&nbsp;","listText":"<a href=\"https://ttm.financial/S/MSFT\">$Microsoft(MSFT)$&nbsp;</a> $416 now... back to Year 2024 prices.. Imagine holding this stock till Jan 2026 and getting nothing in return 😅 So tempted to add MFST but gut feeling says geopolitics will cause the stock to fall much lower.&nbsp;","text":"$Microsoft(MSFT)$ $416 now... back to Year 2024 prices.. Imagine holding this stock till Jan 2026 and getting nothing in return 😅 So tempted to add MFST but gut feeling says geopolitics will cause the stock to fall much lower.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/528823073592016","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":14,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":526822966878864,"gmtCreate":1769654389625,"gmtModify":1769654393755,"author":{"id":"3581654847570147","authorId":"3581654847570147","name":"GreenArt","avatar":"https://static.tigerbbs.com/4da854bffe68ea665dbcd4c6e26e6e53","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581654847570147","idStr":"3581654847570147"},"themes":[],"title":"","htmlText":"I plan to just sell in strength for those going up &gt;5%. Wait for next dip to pick up again...like&nbsp;when the dust settled after reporting season.","listText":"I plan to just sell in strength for those going up &gt;5%. Wait for next dip to pick up again...like&nbsp;when the dust settled after reporting season.","text":"I plan to just sell in strength for those going up >5%. Wait for next dip to pick up again...like when the dust settled after reporting season.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/526822966878864","isVote":1,"tweetType":1,"viewCount":420,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":522743837660240,"gmtCreate":1768658141423,"gmtModify":1768658145043,"author":{"id":"3581654847570147","authorId":"3581654847570147","name":"GreenArt","avatar":"https://static.tigerbbs.com/4da854bffe68ea665dbcd4c6e26e6e53","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581654847570147","idStr":"3581654847570147"},"themes":[],"title":"","htmlText":"Time to add soon?","listText":"Time to add soon?","text":"Time to add soon?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/522743837660240","repostId":"522474440630520","repostType":1,"repost":{"id":522474440630520,"gmtCreate":1768591868323,"gmtModify":1768603169304,"author":{"id":"3560568347001200","authorId":"3560568347001200","name":"Asamayam","avatar":"https://community-static.tradeup.com/news/a3e036d484719e27a9281d1c1864af9f","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560568347001200","idStr":"3560568347001200"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a>Reflection&nbsp; 1. Stick to objective. As my objective is day trading. Then it is a good job that despite the loss, I did not went to do \"dollar-cost averaging\" which I would have suffer even higher losses.&nbsp; 2. Failure on my end to initiate a stop loss. As I am trading using leverage. I could impose a limit on my loss and execute using stop-loss to limit my losses.&nbsp; Despite buying at oversold signal, there wasn't a bounce back.&nbsp;","listText":"<a href=\"https://ttm.financial/S/PLTR\">$Palantir Technologies Inc.(PLTR)$&nbsp;</a>Reflection&nbsp; 1. Stick to objective. As my objective is day trading. Then it is a good job that despite the loss, I did not went to do \"dollar-cost averaging\" which I would have suffer even higher losses.&nbsp; 2. Failure on my end to initiate a stop loss. As I am trading using leverage. I could impose a limit on my loss and execute using stop-loss to limit my losses.&nbsp; Despite buying at oversold signal, there wasn't a bounce back.&nbsp;","text":"$Palantir Technologies Inc.(PLTR)$ Reflection 1. Stick to objective. As my objective is day trading. Then it is a good job that despite the loss, I did not went to do \"dollar-cost averaging\" which I would have suffer even higher losses. 2. Failure on my end to initiate a stop loss. As I am trading using leverage. I could impose a limit on my loss and execute using stop-loss to limit my losses. Despite buying at oversold signal, there wasn't a bounce back.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/522474440630520","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":291,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":522743039657144,"gmtCreate":1768658044955,"gmtModify":1768658048438,"author":{"id":"3581654847570147","authorId":"3581654847570147","name":"GreenArt","avatar":"https://static.tigerbbs.com/4da854bffe68ea665dbcd4c6e26e6e53","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581654847570147","idStr":"3581654847570147"},"themes":[],"title":"","htmlText":"Good to share. Tks!","listText":"Good to share. Tks!","text":"Good to share. Tks!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/522743039657144","repostId":"522241770005872","repostType":1,"repost":{"id":522241770005872,"gmtCreate":1768536402675,"gmtModify":1768672202148,"author":{"id":"4186152209563772","authorId":"4186152209563772","name":"6fddf4a0","avatar":"https://static.tigerbbs.com/5b6644af7864019ae3e0f93cd0bc898c","crmLevel":0,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4186152209563772","idStr":"4186152209563772"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/01810\">$小米集團-W(01810)$&nbsp;</a><v-v data-views=\"0\"></v-v>&nbsp; Who's doing the fake flag operation? Southbound？","listText":"<a href=\"https://laohu8.com/S/01810\">$小米集團-W(01810)$&nbsp;</a><v-v data-views=\"0\"></v-v>&nbsp; Who's doing the fake flag operation? Southbound？","text":"$小米集團-W(01810)$ Who's doing the fake flag operation? Southbound？","images":[{"img":"https://static.tigerbbs.com/6f005fd004f753f8b6badd0e9aa8488b","width":"1316","height":"1950"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/522241770005872","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":206,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":522742748098864,"gmtCreate":1768657944802,"gmtModify":1768657948321,"author":{"id":"3581654847570147","authorId":"3581654847570147","name":"GreenArt","avatar":"https://static.tigerbbs.com/4da854bffe68ea665dbcd4c6e26e6e53","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581654847570147","idStr":"3581654847570147"},"themes":[],"title":"","htmlText":"Great article, would you like to share it?","listText":"Great article, would you like to share it?","text":"Great article, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/522742748098864","repostId":"522200247936304","repostType":1,"repost":{"id":522200247936304,"gmtCreate":1768525539813,"gmtModify":1768582803193,"author":{"id":"3570103090255456","authorId":"3570103090255456","name":"JC888","avatar":"https://community-static.tradeup.com/news/1f15eae4f682dc4cb91bfca455452752","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3570103090255456","idStr":"3570103090255456"},"themes":[],"title":"INTC's MBLY Rally ? It's A Broken Dream !","htmlText":"<a href=\"https://ttm.financial/S/MBLY\">$Mobileye Global Inc.(MBLY)$</a> represents one of the most sophisticated \"pure plays\" in the field of computer vision and autonomous driving. To understand whether MBLY is truly on the verge of a breakout in 2026, one must peel back the layers of its evolution:: Academic origin: A vision born in the labs of Jerusalem. Complex history of its public listings: A triple-jump between being public and private. Recent financial \"inventory shock\": A post-pandemic supply chain hangover. Latest move into humanoid robotics: Moving from the road to the warehouse floor. Background &amp; History. MBLY story began in 1999 in Jerusalem, Israel. At the time, the prevailing wisdom in robotics—led by DARPA Grand Challenge contenders—suggested that autonomous sight requ","listText":"<a href=\"https://ttm.financial/S/MBLY\">$Mobileye Global Inc.(MBLY)$</a> represents one of the most sophisticated \"pure plays\" in the field of computer vision and autonomous driving. To understand whether MBLY is truly on the verge of a breakout in 2026, one must peel back the layers of its evolution:: Academic origin: A vision born in the labs of Jerusalem. Complex history of its public listings: A triple-jump between being public and private. Recent financial \"inventory shock\": A post-pandemic supply chain hangover. Latest move into humanoid robotics: Moving from the road to the warehouse floor. Background &amp; History. MBLY story began in 1999 in Jerusalem, Israel. At the time, the prevailing wisdom in robotics—led by DARPA Grand Challenge contenders—suggested that autonomous sight requ","text":"$Mobileye Global Inc.(MBLY)$ represents one of the most sophisticated \"pure plays\" in the field of computer vision and autonomous driving. To understand whether MBLY is truly on the verge of a breakout in 2026, one must peel back the layers of its evolution:: Academic origin: A vision born in the labs of Jerusalem. Complex history of its public listings: A triple-jump between being public and private. Recent financial \"inventory shock\": A post-pandemic supply chain hangover. Latest move into humanoid robotics: Moving from the road to the warehouse floor. Background & History. MBLY story began in 1999 in Jerusalem, Israel. At the time, the prevailing wisdom in robotics—led by DARPA Grand Challenge contenders—suggested that autonomous sight requ","images":[{"img":"https://community-static.tradeup.com/news/233032d453fb6ffbeaafe68f764d5973","width":"3040","height":"1600"},{"img":"https://community-static.tradeup.com/news/c7d281946a04b2d5237e1e3aa8c40486","width":"435","height":"206"},{"img":"https://community-static.tradeup.com/news/24043ae22cea36361ca29509b9a997c2","width":"806","height":"202"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/522200247936304","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":18,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":273,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":522739624801392,"gmtCreate":1768657211108,"gmtModify":1768657214781,"author":{"id":"3581654847570147","authorId":"3581654847570147","name":"GreenArt","avatar":"https://static.tigerbbs.com/4da854bffe68ea665dbcd4c6e26e6e53","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581654847570147","idStr":"3581654847570147"},"themes":[],"title":"","htmlText":"Hope to see V recovery next week. 😆","listText":"Hope to see V recovery next week. 😆","text":"Hope to see V recovery next week. 😆","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":133,"commentSize":3,"repostSize":73,"link":"https://ttm.financial/post/522739624801392","isVote":1,"tweetType":1,"viewCount":6614,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":520553996792928,"gmtCreate":1768136656124,"gmtModify":1768136660064,"author":{"id":"3581654847570147","authorId":"3581654847570147","name":"GreenArt","avatar":"https://static.tigerbbs.com/4da854bffe68ea665dbcd4c6e26e6e53","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581654847570147","idStr":"3581654847570147"},"themes":[],"title":"","htmlText":"Add to long...&nbsp;","listText":"Add to long...&nbsp;","text":"Add to long...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":2,"link":"https://ttm.financial/post/520553996792928","repostId":"519972794053328","repostType":1,"repost":{"id":519972794053328,"gmtCreate":1767981669861,"gmtModify":1768072802290,"author":{"id":"4171900329979952","authorId":"4171900329979952","name":"Barcode","avatar":"https://community-static.tradeup.com/news/6688d8fb4c2a255e3b901e79755e56df","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4171900329979952","idStr":"4171900329979952"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/TSLA\">$Tesla Motors(TSLA)$</a>&nbsp;<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$&nbsp;</a>&nbsp;<a href=\"https://ttm.financial/S/INTC\">$Intel(INTC)$&nbsp;</a> 09Jan26 ET 🇺🇸 | 10Jan26 NZT 🇳🇿 🚀 $TSLA +$10 now&nbsp; ⏪ Was -$8 vs pre-market earlier ⬆️ Now +$16 off the lows 📆 We’re sitting +$5 on the week — even though $NVDA’s AI autonomy stack was supposed to lead first — even though robotaxi fleets still run with safety drivers and L4 constraints — even though Elon Musk's political noise on X keeps feeding headline volatility 📈 Price before narratives. Always. 🗓️ Key dates now on the radar • 13 Jan hearing on lifting the 2,500 AV cap • 14 Jan Supreme Court opinion on Trump tariffs ⚡ Next week is shaping up volatile for $TSLA 🤖🦾🔋 🚘🤖 ʜᴀᴘᴘʏ TESLA ᴛʀᴀᴅɪɴɢ","listText":"<a href=\"https://ttm.financial/S/TSLA\">$Tesla Motors(TSLA)$</a>&nbsp;<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$&nbsp;</a>&nbsp;<a href=\"https://ttm.financial/S/INTC\">$Intel(INTC)$&nbsp;</a> 09Jan26 ET 🇺🇸 | 10Jan26 NZT 🇳🇿 🚀 $TSLA +$10 now&nbsp; ⏪ Was -$8 vs pre-market earlier ⬆️ Now +$16 off the lows 📆 We’re sitting +$5 on the week — even though $NVDA’s AI autonomy stack was supposed to lead first — even though robotaxi fleets still run with safety drivers and L4 constraints — even though Elon Musk's political noise on X keeps feeding headline volatility 📈 Price before narratives. Always. 🗓️ Key dates now on the radar • 13 Jan hearing on lifting the 2,500 AV cap • 14 Jan Supreme Court opinion on Trump tariffs ⚡ Next week is shaping up volatile for $TSLA 🤖🦾🔋 🚘🤖 ʜᴀᴘᴘʏ TESLA ᴛʀᴀᴅɪɴɢ","text":"$Tesla Motors(TSLA)$ $NVIDIA(NVDA)$ $Intel(INTC)$ 09Jan26 ET 🇺🇸 | 10Jan26 NZT 🇳🇿 🚀 $TSLA +$10 now ⏪ Was -$8 vs pre-market earlier ⬆️ Now +$16 off the lows 📆 We’re sitting +$5 on the week — even though $NVDA’s AI autonomy stack was supposed to lead first — even though robotaxi fleets still run with safety drivers and L4 constraints — even though Elon Musk's political noise on X keeps feeding headline volatility 📈 Price before narratives. Always. 🗓️ Key dates now on the radar • 13 Jan hearing on lifting the 2,500 AV cap • 14 Jan Supreme Court opinion on Trump tariffs ⚡ Next week is shaping up volatile for $TSLA 🤖🦾🔋 🚘🤖 ʜᴀᴘᴘʏ TESLA ᴛʀᴀᴅɪɴɢ","images":[{"img":"https://community-static.tradeup.com/news/ac7fbf6c449ce9ccd9dd9f6db80118bf","width":"1138","height":"1943"},{"img":"https://community-static.tradeup.com/news/7a0756e636ba01c7e482848977770a2b","width":"1472","height":"1202"},{"img":"https://community-static.tradeup.com/news/9f080f09696443332ccd5e3d300b778c","width":"1472","height":"828"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/519972794053328","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":3,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":278,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":516802301149392,"gmtCreate":1767195431316,"gmtModify":1767195434820,"author":{"id":"3581654847570147","authorId":"3581654847570147","name":"GreenArt","avatar":"https://static.tigerbbs.com/4da854bffe68ea665dbcd4c6e26e6e53","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581654847570147","idStr":"3581654847570147"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/ONDS\">$Ondas Holdings Inc.(ONDS)$ </a> Take profits for new year&nbsp;meal.&nbsp;","listText":"<a href=\"https://ttm.financial/S/ONDS\">$Ondas Holdings Inc.(ONDS)$ </a> Take profits for new year&nbsp;meal.&nbsp;","text":"$Ondas Holdings Inc.(ONDS)$ Take profits for new year meal.","images":[{"img":"https://community-static.tradeup.com/news/95307d43d8d6eaa95db1e5cddb0e24d2","width":"876","height":"1720"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/516802301149392","isVote":1,"tweetType":1,"viewCount":410,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":516802243396408,"gmtCreate":1767195344095,"gmtModify":1767195347720,"author":{"id":"3581654847570147","authorId":"3581654847570147","name":"GreenArt","avatar":"https://static.tigerbbs.com/4da854bffe68ea665dbcd4c6e26e6e53","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581654847570147","idStr":"3581654847570147"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/TSM\">$Taiwan Semiconductor Manufacturing(TSM)$ </a> profiting from volatility&nbsp;","listText":"<a href=\"https://ttm.financial/S/TSM\">$Taiwan Semiconductor Manufacturing(TSM)$ </a> profiting from volatility&nbsp;","text":"$Taiwan Semiconductor Manufacturing(TSM)$ profiting from volatility","images":[{"img":"https://community-static.tradeup.com/news/2bd95b552791c4725a6c92cd572889a9","width":"876","height":"1720"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/516802243396408","isVote":1,"tweetType":1,"viewCount":425,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":516801535263480,"gmtCreate":1767195292364,"gmtModify":1767195295735,"author":{"id":"3581654847570147","authorId":"3581654847570147","name":"GreenArt","avatar":"https://static.tigerbbs.com/4da854bffe68ea665dbcd4c6e26e6e53","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581654847570147","idStr":"3581654847570147"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/ONDS\">$Ondas Holdings Inc.(ONDS)$ </a> Take some profit to end the year","listText":"<a href=\"https://ttm.financial/S/ONDS\">$Ondas Holdings Inc.(ONDS)$ </a> Take some profit to end the year","text":"$Ondas Holdings Inc.(ONDS)$ Take some profit to end the year","images":[{"img":"https://community-static.tradeup.com/news/54a3d53ba398b817075bacd04be91261","width":"876","height":"1720"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/516801535263480","isVote":1,"tweetType":1,"viewCount":426,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":515888995725560,"gmtCreate":1766977029491,"gmtModify":1766977033566,"author":{"id":"3581654847570147","authorId":"3581654847570147","name":"GreenArt","avatar":"https://static.tigerbbs.com/4da854bffe68ea665dbcd4c6e26e6e53","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581654847570147","idStr":"3581654847570147"},"themes":[],"title":"","htmlText":"U96 Sembcorp starts to consolidate from low... is it time to accumulate?&nbsp;","listText":"U96 Sembcorp starts to consolidate from low... is it time to accumulate?&nbsp;","text":"U96 Sembcorp starts to consolidate from low... is it time to accumulate?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/515888995725560","repostId":"2592153869","repostType":2,"repost":{"id":"2592153869","kind":"highlight","pubTimestamp":1766113484,"share":"https://ttm.financial/m/news/2592153869?lang=en_US&edition=fundamental","pubTime":"2025-12-19 11:04","market":"us","language":"en","title":"A Look At The Fair Value Of Sembcorp Industries Ltd (SGX:U96)","url":"https://stock-news.laohu8.com/highlight/detail?id=2592153869","media":"Simply Wall St.","summary":"Key Insights Using the Dividend Discount Model, Sembcorp Industries fair value estimate is S$7.35 With S$5.88 share...","content":"<div>\n<p>Key Insights Using the Dividend Discount Model, Sembcorp Industries fair value estimate is S$7.35   With S$5.88 share price, Sembcorp Industries appears to be trading close to its estimated fair value...</p>\n\n<a href=\"https://simplywall.st/stocks/sg/utilities/sgx-u96/sembcorp-industries-shares/news/a-look-at-the-fair-value-of-sembcorp-industries-ltd-sgxu96-1\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A Look At The Fair Value Of Sembcorp Industries Ltd (SGX:U96)</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA Look At The Fair Value Of Sembcorp Industries Ltd (SGX:U96)\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-12-19 11:04 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/sg/utilities/sgx-u96/sembcorp-industries-shares/news/a-look-at-the-fair-value-of-sembcorp-industries-ltd-sgxu96-1><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Key Insights Using the Dividend Discount Model, Sembcorp Industries fair value estimate is S$7.35   With S$5.88 share price, Sembcorp Industries appears to be trading close to its estimated fair value...</p>\n\n<a href=\"https://simplywall.st/stocks/sg/utilities/sgx-u96/sembcorp-industries-shares/news/a-look-at-the-fair-value-of-sembcorp-industries-ltd-sgxu96-1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://images.simplywall.st/asset/industry/9541000-choice2-main-header/1585186794818","relate_stocks":{"BK4007":"制药","SG9999016042.SGD":"Schroder Singapore Trust A Acc SGD","SG9999001135.SGD":"United ASEAN Fund SGD","SG9999014492.USD":"NIKKO AM ASEAN EQUITY \"A\" (USD) ACC","SG9999014484.SGD":"Nikko AM ASEAN Equity Fund A SGD","IE00BYTNYN87.SGD":"PINEBRIDGE ASIA EX JAPAN SMALL CAP EQUITY \"A5\" (SGD) ACC","BK6500":"公用股","IE00B12V2V27.USD":"柏瑞亚洲小盘股A(除日本)","SG9999004360.SGD":"Nikko AM Shenton Thrift Fund SGD","IE00BYQNZ168.SGD":"PINEBRIDGE ASIA EX JAPAN SMALL CAP EQUITY \"A5CP\" (SGD) ACC","BK6113":"复合型公用事业","SG9999001226.SGD":"UNITED SUSTAINABLE ASIA TOP 50 \"A\" (SGD) ACC","BK4213":"石油与天然气的勘探与生产","SGXZ27511609.SGD":"NIKKO AM SINGAPORE DIVIDEND EQUITY \"SGD\" (SGD) ACC","SG9999011746.SGD":"PINEBRIDGE INTERNATIONAL FUNDS - ACORNS OF ASIA BA (SGD) ACC","SG9999000475.SGD":"Aberdeen Standard Singapore Equity SGD","SG9999003826.SGD":"日兴资管新加坡股息基金 SGD","LU2238330802.EUR":"AZ EQUITY - ASEAN COUNTRIES \"AAZ\" (EUR) ACC","U96.SI":"胜科工业","SG9999000343.SGD":"Schroder Singapore Trust A Dis SGD","SG9999008742.SGD":"Eastspring Investments Unit Trusts - Singapore ASEAN Equity SGD","SG9999006266.SGD":"MANULIFE SINGAPORE EQUITY \"A\" (SGD) ACC","SGXZ43160589.SGD":"UNITED SG DYNAMIC INCOME FUND \"A\" (SGD) ACC","SGXZ24219693.SGD":"UNITED SG DYNAMIC INCOME FUND \"A\" (SGD) INC"},"source_url":"https://simplywall.st/stocks/sg/utilities/sgx-u96/sembcorp-industries-shares/news/a-look-at-the-fair-value-of-sembcorp-industries-ltd-sgxu96-1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2592153869","content_text":"Key Insights Using the Dividend Discount Model, Sembcorp Industries fair value estimate is S$7.35   With S$5.88 share price, Sembcorp Industries appears to be trading close to its estimated fair value    The S$7.15 analyst price target for U96 is 2.7% less than our estimate of fair value   Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Sembcorp Industries Ltd (SGX:U96) as an investment opportunity  by taking the expected future cash flows and discounting them to today's value.  This will be done using the Discounted Cash Flow (DCF) model.  Believe it or not, it's not too difficult to follow, as you'll see from our example!  We generally believe that a company's value is the present value of all of the cash it will generate in the future. However, a DCF is just one valuation metric among many, and it is not without flaws.  For those who are keen learners of equity analysis, the Simply Wall St analysis model here may be something of interest to you. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. Step By Step Through The Calculation   As Sembcorp Industries operates in the integrated utilities sector, we need to calculate the intrinsic value slightly differently.  Instead of using free cash flows, which are hard to estimate and often not reported by analysts in this industry, dividends per share (DPS) payments are used.  This often underestimates the value of a stock, but it can still be good as a comparison to competitors.  The 'Gordon Growth Model' is used, which simply assumes that dividend payments will continue to increase at a sustainable growth rate forever.  For a number of reasons a very conservative growth rate is used that cannot exceed that of a company's Gross Domestic Product (GDP). In this case we used the 5-year average of the 10-year government bond yield (2.5%). The expected dividend per share is then discounted to today's value at a cost of equity of 5.8%.  Relative to the current share price of S$5.9, the company appears   about fair value    at a 20% discount to where the stock price trades currently.   Valuations are imprecise instruments though, rather like a telescope - move a few degrees and end up in a different galaxy. Do keep this in mind. Value Per Share = Expected Dividend Per Share / (Discount Rate - Perpetual Growth Rate)= S$0.2 / (5.8% – 2.5%)= S$7.3SGX:U96 Discounted Cash Flow December 19th 2025  Important Assumptions  The calculation above is very dependent on two assumptions. The first is the discount rate and the other is the cash flows.  Part of investing is coming up with your own evaluation of a company's future performance, so try the calculation yourself and check your own assumptions.  The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance.  Given that we are looking at Sembcorp Industries as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt.  In this calculation we've used 5.8%, which is based on a levered beta of 0.800. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.   Check out our latest analysis for Sembcorp Industries SWOT Analysis for Sembcorp IndustriesStrength Earnings growth over the past year exceeded the industry. Debt is well covered by earnings. Balance sheet summary for U96. Weakness Earnings growth over the past year is below its 5-year average. Dividend is low compared to the top 25% of dividend payers in the Integrated Utilities market.Opportunity Annual revenue is forecast to grow faster than the Singaporean market.  Current share price is below our estimate of fair value. ThreatDebt is not well covered by operating cash flow. Dividends are not covered by cash flow.  Annual earnings are forecast to grow slower than the Singaporean market. Is U96 well equipped to handle threats?  Looking Ahead:  Whilst important, the DCF calculation  shouldn't be the only metric you look at when researching a company.  The DCF model is not a perfect stock valuation tool.  Preferably you'd apply different cases and assumptions and see how they would impact the company's valuation.  For instance, if the terminal value growth rate is adjusted slightly, it can dramatically alter the overall result.  For Sembcorp Industries, we've put together three  additional  aspects  you should further research:   Risks: For instance, we've identified   2 warning signs for Sembcorp Industries (1 makes us a bit uncomfortable)  you should be aware of.  Future Earnings: How does U96's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart. Other High Quality Alternatives: Do you like a good all-rounder? Explore our interactive list of high quality stocks to get an idea of what else is out there you may be missing!   PS. The Simply Wall St app conducts a discounted cash flow valuation for every stock on the SGX every day. If you want to find the calculation for other stocks just search here.Mobile Infrastructure for Defense and DisasterThe next wave in robotics isn't humanoid. Its fully autonomous towers delivering 5G, ISR, and radar in under 30 minutes, anywhere.Get the investor briefing before the next round of contractsSponsored On Behalf of CiTechNew: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.","news_type":1,"symbols_score_info":{"U96.SI":1.98}},"isVote":1,"tweetType":1,"viewCount":575,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":515009193623712,"gmtCreate":1766762233791,"gmtModify":1766762238013,"author":{"id":"3581654847570147","authorId":"3581654847570147","name":"GreenArt","avatar":"https://static.tigerbbs.com/4da854bffe68ea665dbcd4c6e26e6e53","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581654847570147","idStr":"3581654847570147"},"themes":[],"htmlText":"Disappointed with all the experts &amp; guru commenting on high chance of Santa Rally... luckily I am prepared for the opposite. Stay calm folks! Let's wait a few more days... good luck! 🫠","listText":"Disappointed with all the experts &amp; guru commenting on high chance of Santa Rally... luckily I am prepared for the opposite. Stay calm folks! Let's wait a few more days... good luck! 🫠","text":"Disappointed with all the experts & guru commenting on high chance of Santa Rally... luckily I am prepared for the opposite. Stay calm folks! Let's wait a few more days... good luck! 🫠","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/515009193623712","isVote":1,"tweetType":1,"viewCount":635,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":512511135658440,"gmtCreate":1766152424332,"gmtModify":1766152427900,"author":{"id":"3581654847570147","authorId":"3581654847570147","name":"GreenArt","avatar":"https://static.tigerbbs.com/4da854bffe68ea665dbcd4c6e26e6e53","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581654847570147","idStr":"3581654847570147"},"themes":[],"htmlText":"WAIT!","listText":"WAIT!","text":"WAIT!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/512511135658440","isVote":1,"tweetType":1,"viewCount":393,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":509686530469968,"gmtCreate":1765466706783,"gmtModify":1765466712007,"author":{"id":"3581654847570147","authorId":"3581654847570147","name":"GreenArt","avatar":"https://static.tigerbbs.com/4da854bffe68ea665dbcd4c6e26e6e53","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581654847570147","idStr":"3581654847570147"},"themes":[],"htmlText":"It is the next stage of AI. Imagine performing AI in the environment that constantly cooling down the power generated from AI chips. A big saving in energy. Imagine you calculate &amp; performing all the weather forecast out of space then send it back... edge- AI. And many other task that uses the satellite...all out from Space-AI. It will be very interesting to watch this Sci friction unfolding in our lifetime. Don't miss it...but watch where you put your money.","listText":"It is the next stage of AI. Imagine performing AI in the environment that constantly cooling down the power generated from AI chips. A big saving in energy. Imagine you calculate &amp; performing all the weather forecast out of space then send it back... edge- AI. And many other task that uses the satellite...all out from Space-AI. It will be very interesting to watch this Sci friction unfolding in our lifetime. Don't miss it...but watch where you put your money.","text":"It is the next stage of AI. Imagine performing AI in the environment that constantly cooling down the power generated from AI chips. A big saving in energy. Imagine you calculate & performing all the weather forecast out of space then send it back... edge- AI. And many other task that uses the satellite...all out from Space-AI. It will be very interesting to watch this Sci friction unfolding in our lifetime. Don't miss it...but watch where you put your money.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/509686530469968","isVote":1,"tweetType":1,"viewCount":992,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":508538498933216,"gmtCreate":1765176694555,"gmtModify":1765176698351,"author":{"id":"3581654847570147","authorId":"3581654847570147","name":"GreenArt","avatar":"https://static.tigerbbs.com/4da854bffe68ea665dbcd4c6e26e6e53","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581654847570147","idStr":"3581654847570147"},"themes":[],"title":"","htmlText":"Caution..","listText":"Caution..","text":"Caution..","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/508538498933216","repostId":"2589052871","repostType":2,"repost":{"id":"2589052871","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1765170190,"share":"https://ttm.financial/m/news/2589052871?lang=en_US&edition=fundamental","pubTime":"2025-12-08 13:03","market":"nz","language":"en","title":"Why Nvidia and Other AI Stocks Have Lost Their \"Quality\" Status","url":"https://stock-news.laohu8.com/highlight/detail?id=2589052871","media":"Dow Jones","summary":"Are the big AI companies giving up their status as the highest caliber stocks in the market?The question is at the heart of a debate about \"quality\" companies that has left two popular ETFs with wildly different performance after one ditched Nvidia and most of the rest of Big Tech.The $48 billion iShares MSCI USA Quality Factor  and Invesco's $15 billion S&P 500 Quality  specialize in what the investment industry has dubbed quality companies. The exchange-traded funds invest only in companies that show they are safe and steady on financial measures including high profitability and low leverage.In Nvidia's case, there has been a jump in working capital as rapid sales growth has led to immediate costs, while payments from customers lag behind. In the latest quarter, money owed by customers, known as accounts receivable, leapt by $16 billion from the year before, to $33 billion, while money owed to suppliers, accounts payable, rose only $3 billion, to $8 billion. The gap between the two h","content":"<html><head></head><body><p>Are the big AI companies giving up their status as the highest caliber stocks in the market? The question is at the heart of a debate about &#34;quality&#34; companies that has left two popular ETFs with wildly different performance after one ditched <a href=\"https://laohu8.com/S/NVDA\">Nvidia</a> and most of the rest of Big Tech.</p><p>The $48 billion  <a href=\"https://laohu8.com/S/QUAL\">iShares MSCI USA Quality Factor ETF</a>  and Invesco&#39;s $15 billion  <a href=\"https://laohu8.com/S/SPHQ\">Invesco S&amp;P 500 Quality ETF</a>  specialize in what the investment industry has dubbed quality companies. The exchange-traded funds invest only in companies that show they are safe and steady on financial measures including high profitability and low leverage.</p><p>The benchmarks that these two ETFs use to measure quality have a crucial difference, which leads to one having much more exposure to the major artificial-intelligence stocks. QUAL, which bases its definition of quality on an MSCI index, has almost a third of its holdings in five of the leading eight Big Tech stocks. SPHQ, which is based on an S&amp;P index, holds only one, Apple.</p><p>The result has been wild swings in performance. Up to June, when Invesco dropped Nvidia, SPHQ beat QUAL by the most in any six-month period. In the past six months SPHQ has lagged behind by the most, aside from the period immediately after QUAL got going in 2013.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/7c5b0611dbb2c24fa1ec06883fad7708\" tg-width=\"639\" tg-height=\"513\"/></p><p>This is much more than a semantic debate between ETFs about what quality means. It goes to the heart of a much bigger question in markets: Is the bet on AI being made by the country&#39;s biggest companies a vast potential profit pool or a money pit that should be sounding alarm bells?</p><p>In addition to Nvidia, SPHQ dropped <a href=\"https://laohu8.com/S/META\">Meta</a> and  <a href=\"https://laohu8.com/S/NFLX\">Netflix</a>  in June, and Microsoft last December. The culprit, according to Nick Kalivas, head of factor and equity ETF strategy at Invesco, was the accounting concept of accruals.</p><p>Accruals are a way to gauge how much of reported earnings are based on sales that generate cash right away, rather than money owed by customers in the future or other noncash items. Cash today is obviously preferable to a promise that money will come through in the future. Things can go wrong. Customers go bust, economies change.</p><p>The S&amp;P index behind the fund uses accruals as one of its three indicators, because high accruals are sometimes a sign of trouble ahead.</p><p>&#34;You start to see a deterioration in the cash component of earnings, and that might indicate that your strength and the durability of your earnings might be coming under pressure,&#34; Kalivas said.</p><p>In Nvidia&#39;s case, there has been a jump in working capital as rapid sales growth has led to immediate costs, while payments from customers lag behind. In the latest quarter, money owed by customers, known as accounts receivable, leapt by $16 billion from the year before, to $33 billion, while money owed to suppliers, accounts payable, rose only $3 billion, to $8 billion. The gap between the two has to be funded by the company while it waits to be paid.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/35ede62534ddc2e429a2433954b3682d\" tg-width=\"634\" tg-height=\"511\"/></p><p>QUAL&#39;s index doesn&#39;t exclude stocks based on accruals, instead looking for steady earnings growth, which these Big Tech names have in spades. MSCI, which runs the index behind the fund, consulted customers about adding accruals last year, but decided against the move after finding it would lead to more churn in the stocks that qualify.</p><p>Rising accruals may be part of the problem that the market began worrying about a few weeks ago: Big Tech companies are pouring hundreds of billions of dollars into AI without a clear path to profit, eating into their cash on hand and increasingly needing borrowing to finance it.</p><p>Investing real money now and hoping for payments some time in the future is the core of investment. But big companies rarely spend so much on a technology where uncertainties are so high.</p><p>Wei Li, chief investment strategist at the BlackRock Investment Institute, thinks there is still more to go in the bull market. But she said the uncertainties are so big it isn&#39;t even worth trying to forecast how much productivity -- and so adoption and profit -- AI might lead to.</p><p>&#34;We spend first, and we&#39;re hoping that at some point revenue will come,&#34; she said. &#34;But that hasn&#39;t happened yet.&#34;</p><p>Quality stocks don&#39;t usually come with so much uncertainty about where they allocate their capital. But it&#39;s also undeniable that Nvidia and most other Big Tech stocks have been exceptionally profitable as the AI boom intensified.</p><p>The accruals happening here aren&#39;t the sort of accruals that make investors the most nervous. Forensic accountants worry about rising accruals as a sign of earnings manipulation or fraud, but that isn&#39;t the concern here.</p><p>Helen Jewell, chief investment officer for fundamental equities at BlackRock, uses an accruals-like measure -- cash conversion -- as part of stock selection and said the point is to identify companies able to get into a &#34;virtuous cycle&#34; of investment.</p><p>&#34;If you have got strong earnings and cash flow, it allows you to continuously reinvest,&#34; she said. That investment makes more money, allowing more investment, and so on.</p><p>A separate academic finding used by neither ETF has long established that when companies splurge on capital spending, as the AI firms are now, their shares typically lag behind the rest of the market in the future. Investment strategists have been rediscovering the depressing historical link recently.</p><p>Yet, all this effort might be beside the point, said Mamdouh Medhat, research director at Dimensional Fund Advisors. He argues that there&#39;s no need to overcomplicate quality gauges: A strategy of just buying the most profitable stocks trading at lower valuations, on average beat combined measures with accruals, stability of earnings or other tricks.</p><p>Outside the smallest companies, such a strategy already captures any gains from avoiding high-capex stocks, he says. Put simply: Don&#39;t buy bad companies, and don&#39;t buy the most expensive companies.</p><p>For me, the point of any quality approach is to spot strong companies where management resists the temptation to throw money at the latest fad. AI is definitely in fashion, and management is throwing money at it.</p><p>Investing based on factors aims to deliver a small premium that adds up over time. The problem with today&#39;s market is that a handful of stocks are so big that including them, or not, can deliver, or miss out on, years of these gains in a few months. The result is that which ETF does better from here depends on investor appetite for AI at least as much as it does on quality.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Nvidia and Other AI Stocks Have Lost Their \"Quality\" Status</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Nvidia and Other AI Stocks Have Lost Their \"Quality\" Status\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-12-08 13:03</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Are the big AI companies giving up their status as the highest caliber stocks in the market? The question is at the heart of a debate about &#34;quality&#34; companies that has left two popular ETFs with wildly different performance after one ditched <a href=\"https://laohu8.com/S/NVDA\">Nvidia</a> and most of the rest of Big Tech.</p><p>The $48 billion  <a href=\"https://laohu8.com/S/QUAL\">iShares MSCI USA Quality Factor ETF</a>  and Invesco&#39;s $15 billion  <a href=\"https://laohu8.com/S/SPHQ\">Invesco S&amp;P 500 Quality ETF</a>  specialize in what the investment industry has dubbed quality companies. The exchange-traded funds invest only in companies that show they are safe and steady on financial measures including high profitability and low leverage.</p><p>The benchmarks that these two ETFs use to measure quality have a crucial difference, which leads to one having much more exposure to the major artificial-intelligence stocks. QUAL, which bases its definition of quality on an MSCI index, has almost a third of its holdings in five of the leading eight Big Tech stocks. SPHQ, which is based on an S&amp;P index, holds only one, Apple.</p><p>The result has been wild swings in performance. Up to June, when Invesco dropped Nvidia, SPHQ beat QUAL by the most in any six-month period. In the past six months SPHQ has lagged behind by the most, aside from the period immediately after QUAL got going in 2013.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/7c5b0611dbb2c24fa1ec06883fad7708\" tg-width=\"639\" tg-height=\"513\"/></p><p>This is much more than a semantic debate between ETFs about what quality means. It goes to the heart of a much bigger question in markets: Is the bet on AI being made by the country&#39;s biggest companies a vast potential profit pool or a money pit that should be sounding alarm bells?</p><p>In addition to Nvidia, SPHQ dropped <a href=\"https://laohu8.com/S/META\">Meta</a> and  <a href=\"https://laohu8.com/S/NFLX\">Netflix</a>  in June, and Microsoft last December. The culprit, according to Nick Kalivas, head of factor and equity ETF strategy at Invesco, was the accounting concept of accruals.</p><p>Accruals are a way to gauge how much of reported earnings are based on sales that generate cash right away, rather than money owed by customers in the future or other noncash items. Cash today is obviously preferable to a promise that money will come through in the future. Things can go wrong. Customers go bust, economies change.</p><p>The S&amp;P index behind the fund uses accruals as one of its three indicators, because high accruals are sometimes a sign of trouble ahead.</p><p>&#34;You start to see a deterioration in the cash component of earnings, and that might indicate that your strength and the durability of your earnings might be coming under pressure,&#34; Kalivas said.</p><p>In Nvidia&#39;s case, there has been a jump in working capital as rapid sales growth has led to immediate costs, while payments from customers lag behind. In the latest quarter, money owed by customers, known as accounts receivable, leapt by $16 billion from the year before, to $33 billion, while money owed to suppliers, accounts payable, rose only $3 billion, to $8 billion. The gap between the two has to be funded by the company while it waits to be paid.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/35ede62534ddc2e429a2433954b3682d\" tg-width=\"634\" tg-height=\"511\"/></p><p>QUAL&#39;s index doesn&#39;t exclude stocks based on accruals, instead looking for steady earnings growth, which these Big Tech names have in spades. MSCI, which runs the index behind the fund, consulted customers about adding accruals last year, but decided against the move after finding it would lead to more churn in the stocks that qualify.</p><p>Rising accruals may be part of the problem that the market began worrying about a few weeks ago: Big Tech companies are pouring hundreds of billions of dollars into AI without a clear path to profit, eating into their cash on hand and increasingly needing borrowing to finance it.</p><p>Investing real money now and hoping for payments some time in the future is the core of investment. But big companies rarely spend so much on a technology where uncertainties are so high.</p><p>Wei Li, chief investment strategist at the BlackRock Investment Institute, thinks there is still more to go in the bull market. But she said the uncertainties are so big it isn&#39;t even worth trying to forecast how much productivity -- and so adoption and profit -- AI might lead to.</p><p>&#34;We spend first, and we&#39;re hoping that at some point revenue will come,&#34; she said. &#34;But that hasn&#39;t happened yet.&#34;</p><p>Quality stocks don&#39;t usually come with so much uncertainty about where they allocate their capital. But it&#39;s also undeniable that Nvidia and most other Big Tech stocks have been exceptionally profitable as the AI boom intensified.</p><p>The accruals happening here aren&#39;t the sort of accruals that make investors the most nervous. Forensic accountants worry about rising accruals as a sign of earnings manipulation or fraud, but that isn&#39;t the concern here.</p><p>Helen Jewell, chief investment officer for fundamental equities at BlackRock, uses an accruals-like measure -- cash conversion -- as part of stock selection and said the point is to identify companies able to get into a &#34;virtuous cycle&#34; of investment.</p><p>&#34;If you have got strong earnings and cash flow, it allows you to continuously reinvest,&#34; she said. That investment makes more money, allowing more investment, and so on.</p><p>A separate academic finding used by neither ETF has long established that when companies splurge on capital spending, as the AI firms are now, their shares typically lag behind the rest of the market in the future. Investment strategists have been rediscovering the depressing historical link recently.</p><p>Yet, all this effort might be beside the point, said Mamdouh Medhat, research director at Dimensional Fund Advisors. He argues that there&#39;s no need to overcomplicate quality gauges: A strategy of just buying the most profitable stocks trading at lower valuations, on average beat combined measures with accruals, stability of earnings or other tricks.</p><p>Outside the smallest companies, such a strategy already captures any gains from avoiding high-capex stocks, he says. Put simply: Don&#39;t buy bad companies, and don&#39;t buy the most expensive companies.</p><p>For me, the point of any quality approach is to spot strong companies where management resists the temptation to throw money at the latest fad. AI is definitely in fashion, and management is throwing money at it.</p><p>Investing based on factors aims to deliver a small premium that adds up over time. The problem with today&#39;s market is that a handful of stocks are so big that including them, or not, can deliver, or miss out on, years of these gains in a few months. The result is that which ETF does better from here depends on investor appetite for AI at least as much as it does on quality.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVDA":"英伟达"},"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2589052871","content_text":"Are the big AI companies giving up their status as the highest caliber stocks in the market? The question is at the heart of a debate about \"quality\" companies that has left two popular ETFs with wildly different performance after one ditched Nvidia and most of the rest of Big Tech.The $48 billion  iShares MSCI USA Quality Factor ETF  and Invesco's $15 billion  Invesco S&P 500 Quality ETF  specialize in what the investment industry has dubbed quality companies. The exchange-traded funds invest only in companies that show they are safe and steady on financial measures including high profitability and low leverage.The benchmarks that these two ETFs use to measure quality have a crucial difference, which leads to one having much more exposure to the major artificial-intelligence stocks. QUAL, which bases its definition of quality on an MSCI index, has almost a third of its holdings in five of the leading eight Big Tech stocks. SPHQ, which is based on an S&P index, holds only one, Apple.The result has been wild swings in performance. Up to June, when Invesco dropped Nvidia, SPHQ beat QUAL by the most in any six-month period. In the past six months SPHQ has lagged behind by the most, aside from the period immediately after QUAL got going in 2013.This is much more than a semantic debate between ETFs about what quality means. It goes to the heart of a much bigger question in markets: Is the bet on AI being made by the country's biggest companies a vast potential profit pool or a money pit that should be sounding alarm bells?In addition to Nvidia, SPHQ dropped Meta and  Netflix  in June, and Microsoft last December. The culprit, according to Nick Kalivas, head of factor and equity ETF strategy at Invesco, was the accounting concept of accruals.Accruals are a way to gauge how much of reported earnings are based on sales that generate cash right away, rather than money owed by customers in the future or other noncash items. Cash today is obviously preferable to a promise that money will come through in the future. Things can go wrong. Customers go bust, economies change.The S&P index behind the fund uses accruals as one of its three indicators, because high accruals are sometimes a sign of trouble ahead.\"You start to see a deterioration in the cash component of earnings, and that might indicate that your strength and the durability of your earnings might be coming under pressure,\" Kalivas said.In Nvidia's case, there has been a jump in working capital as rapid sales growth has led to immediate costs, while payments from customers lag behind. In the latest quarter, money owed by customers, known as accounts receivable, leapt by $16 billion from the year before, to $33 billion, while money owed to suppliers, accounts payable, rose only $3 billion, to $8 billion. The gap between the two has to be funded by the company while it waits to be paid.QUAL's index doesn't exclude stocks based on accruals, instead looking for steady earnings growth, which these Big Tech names have in spades. MSCI, which runs the index behind the fund, consulted customers about adding accruals last year, but decided against the move after finding it would lead to more churn in the stocks that qualify.Rising accruals may be part of the problem that the market began worrying about a few weeks ago: Big Tech companies are pouring hundreds of billions of dollars into AI without a clear path to profit, eating into their cash on hand and increasingly needing borrowing to finance it.Investing real money now and hoping for payments some time in the future is the core of investment. But big companies rarely spend so much on a technology where uncertainties are so high.Wei Li, chief investment strategist at the BlackRock Investment Institute, thinks there is still more to go in the bull market. But she said the uncertainties are so big it isn't even worth trying to forecast how much productivity -- and so adoption and profit -- AI might lead to.\"We spend first, and we're hoping that at some point revenue will come,\" she said. \"But that hasn't happened yet.\"Quality stocks don't usually come with so much uncertainty about where they allocate their capital. But it's also undeniable that Nvidia and most other Big Tech stocks have been exceptionally profitable as the AI boom intensified.The accruals happening here aren't the sort of accruals that make investors the most nervous. Forensic accountants worry about rising accruals as a sign of earnings manipulation or fraud, but that isn't the concern here.Helen Jewell, chief investment officer for fundamental equities at BlackRock, uses an accruals-like measure -- cash conversion -- as part of stock selection and said the point is to identify companies able to get into a \"virtuous cycle\" of investment.\"If you have got strong earnings and cash flow, it allows you to continuously reinvest,\" she said. That investment makes more money, allowing more investment, and so on.A separate academic finding used by neither ETF has long established that when companies splurge on capital spending, as the AI firms are now, their shares typically lag behind the rest of the market in the future. Investment strategists have been rediscovering the depressing historical link recently.Yet, all this effort might be beside the point, said Mamdouh Medhat, research director at Dimensional Fund Advisors. He argues that there's no need to overcomplicate quality gauges: A strategy of just buying the most profitable stocks trading at lower valuations, on average beat combined measures with accruals, stability of earnings or other tricks.Outside the smallest companies, such a strategy already captures any gains from avoiding high-capex stocks, he says. Put simply: Don't buy bad companies, and don't buy the most expensive companies.For me, the point of any quality approach is to spot strong companies where management resists the temptation to throw money at the latest fad. AI is definitely in fashion, and management is throwing money at it.Investing based on factors aims to deliver a small premium that adds up over time. The problem with today's market is that a handful of stocks are so big that including them, or not, can deliver, or miss out on, years of these gains in a few months. The result is that which ETF does better from here depends on investor appetite for AI at least as much as it does on quality.","news_type":1,"symbols_score_info":{"NVDA":2}},"isVote":1,"tweetType":1,"viewCount":868,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":507997588169520,"gmtCreate":1765044561317,"gmtModify":1765044566265,"author":{"id":"3581654847570147","authorId":"3581654847570147","name":"GreenArt","avatar":"https://static.tigerbbs.com/4da854bffe68ea665dbcd4c6e26e6e53","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581654847570147","idStr":"3581654847570147"},"themes":[],"title":"","htmlText":"The major composite in SGX comes from the top 3 banks followed by Reits &amp; other blue chips. Once these banks do well, SGX will likely to&nbsp;do well too. But to reach 6000 in 2026 means 1000 upside within a year, indeed a little too optimistic.&nbsp; I predict it will be around 5800 instead.&nbsp; Well, look at over the&nbsp;years, do we have many 500 jump?&nbsp; The money will go to more exciting &amp; fast pace mkt. And we know local mkt still take time to revamp.&nbsp;","listText":"The major composite in SGX comes from the top 3 banks followed by Reits &amp; other blue chips. Once these banks do well, SGX will likely to&nbsp;do well too. But to reach 6000 in 2026 means 1000 upside within a year, indeed a little too optimistic.&nbsp; I predict it will be around 5800 instead.&nbsp; Well, look at over the&nbsp;years, do we have many 500 jump?&nbsp; The money will go to more exciting &amp; fast pace mkt. And we know local mkt still take time to revamp.&nbsp;","text":"The major composite in SGX comes from the top 3 banks followed by Reits & other blue chips. Once these banks do well, SGX will likely to do well too. But to reach 6000 in 2026 means 1000 upside within a year, indeed a little too optimistic. I predict it will be around 5800 instead. Well, look at over the years, do we have many 500 jump? The money will go to more exciting & fast pace mkt. And we know local mkt still take time to revamp.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/507997588169520","isVote":1,"tweetType":1,"viewCount":1282,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":506499938161392,"gmtCreate":1764678922276,"gmtModify":1764678925600,"author":{"id":"3581654847570147","authorId":"3581654847570147","name":"GreenArt","avatar":"https://static.tigerbbs.com/4da854bffe68ea665dbcd4c6e26e6e53","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581654847570147","idStr":"3581654847570147"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/ONDS\">$Ondas Holdings Inc.(ONDS)$ </a> Sold partial. Brought back after it pulled back again. Waiting for next trade.","listText":"<a href=\"https://ttm.financial/S/ONDS\">$Ondas Holdings Inc.(ONDS)$ </a> Sold partial. Brought back after it pulled back again. Waiting for next trade.","text":"$Ondas Holdings Inc.(ONDS)$ Sold partial. Brought back after it pulled back again. Waiting for next trade.","images":[{"img":"https://community-static.tradeup.com/news/417c621f7d43ff3e2f7f5557bf0eefd8","width":"876","height":"1720"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/506499938161392","isVote":1,"tweetType":1,"viewCount":648,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":504369986650784,"gmtCreate":1764164425465,"gmtModify":1764164429439,"author":{"id":"3581654847570147","authorId":"3581654847570147","name":"GreenArt","avatar":"https://static.tigerbbs.com/4da854bffe68ea665dbcd4c6e26e6e53","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581654847570147","idStr":"3581654847570147"},"themes":[],"title":"","htmlText":"May not justify Fed rate cut.","listText":"May not justify Fed rate cut.","text":"May not justify Fed rate cut.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/504369986650784","repostId":"1136974111","repostType":2,"repost":{"id":"1136974111","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1764163854,"share":"https://ttm.financial/m/news/1136974111?lang=en_US&edition=fundamental","pubTime":"2025-11-26 21:30","market":"us","language":"en","title":"US Weekly Initial Jobless Claims 216K (Est. 225K, Prior 222K Revised from 220K)","url":"https://stock-news.laohu8.com/highlight/detail?id=1136974111","media":"Tiger Newspress","summary":"US Weekly Initial Jobless Claims 216K (Est. 225K, Prior 222K Revised from 220K)","content":"<html><head></head><body>US Weekly Initial Jobless Claims 216K (Est. 225K, Prior 222K Revised from 220K)</body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US Weekly Initial Jobless Claims 216K (Est. 225K, Prior 222K Revised from 220K)</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS Weekly Initial Jobless Claims 216K (Est. 225K, Prior 222K Revised from 220K)\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2025-11-26 21:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body>US Weekly Initial Jobless Claims 216K (Est. 225K, Prior 222K Revised from 220K)</body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index","TQQQ":"纳指三倍做多ETF","SPY":"标普500ETF","SQQQ":"纳指三倍做空ETF",".IXIC":"NASDAQ Composite","QQQ":"纳指100ETF",".DJI":"道琼斯"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1136974111","content_text":"US Weekly Initial Jobless Claims 216K (Est. 225K, Prior 222K Revised from 220K)","news_type":1,"symbols_score_info":{"SPY":1,"YMmain":1,".IXIC":1,"QQQ":1,"TQQQ":1,".DJI":1,".SPX":1,"SQQQ":1,"NQmain":1,"ESmain":1}},"isVote":1,"tweetType":1,"viewCount":646,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":503959733482032,"gmtCreate":1764074254527,"gmtModify":1764115852908,"author":{"id":"3581654847570147","authorId":"3581654847570147","name":"GreenArt","avatar":"https://static.tigerbbs.com/4da854bffe68ea665dbcd4c6e26e6e53","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581654847570147","idStr":"3581654847570147"},"themes":[],"title":"","htmlText":"Hope this unpolished gem 💎 will grow soon.&nbsp; And with the latest acquisition on T cell technology,&nbsp; worth to take a look and put into my watch list. Support local biotech! Time to fly! GDTC","listText":"Hope this unpolished gem 💎 will grow soon.&nbsp; And with the latest acquisition on T cell technology,&nbsp; worth to take a look and put into my watch list. Support local biotech! Time to fly! GDTC","text":"Hope this unpolished gem 💎 will grow soon. And with the latest acquisition on T cell technology, worth to take a look and put into my watch list. Support local biotech! Time to fly! GDTC","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/503959733482032","repostId":"2581093986","repostType":2,"repost":{"id":"2581093986","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1762434000,"share":"https://ttm.financial/m/news/2581093986?lang=en_US&edition=fundamental","pubTime":"2025-11-06 21:00","market":"sh","language":"en","title":"Press Release: CytoMed Therapeutics Secures Non-Dilutive Investment for Subsidiary LongevityBank from ICH Capital and Updates on New China Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2581093986","media":"Dow Jones","summary":"SINGAPORE, Nov. 06, 2025  -- CytoMed Therapeutics Limited  , a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary technologies to develop novel affordable donor-derived cell-based immunotherapies for the treatment of a broad range of cancers, including both blood and solid tumours, announced today that it secures non-dilutive investment for its subsidiary, LongevityBank Pte Ltd  from ICH Capital Pte Ltd .China's State Council Decree No. 818 released on October 10, 2025 establishes a definitive regulatory pathway from clinical research to reimbursable clinical application for cell therapies. The key distinction is that these therapies are to be regulated as biotechnological medical procedures under a 'clinical study to clinical ap","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     SINGAPORE, Nov. 06, 2025 (GLOBE NEWSWIRE) -- <a href=\"https://laohu8.com/S/GDTC\">CytoMed Therapeutics Limited</a> (NASDAQ: GDTC) (\"CytoMed\" or \"Company\"), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary technologies to develop novel affordable donor-derived cell-based immunotherapies for the treatment of a broad range of cancers, including both blood and solid tumours, announced today that it secures non-dilutive investment for its subsidiary, LongevityBank Pte Ltd (\"LongevityBank\") from ICH Capital Pte Ltd (\"ICH Capital\"). \n</p>\n<p>\n     Following the announcement dated August 28, 2025, the strategic vision is for LongevityBank to focus on autologous (using one's own blood, cells and/or tissues) therapies leveraging its personalized cellular banking services while parent company, CytoMed focuses on donor blood-derived allogeneic (using donated blood, cells and/or tissues) therapies which already has an approved IND Phase I clinical trial ongoing in Singapore and a Phase II Investigator-Initiated Trial (IIT) in India. Allogeneic therapies have the advantage of treatment speed, accessibility and cost-effectiveness. Autologous therapies are less likely to be rejected by one's own immune system and are better tolerated with higher acceptance level by the immune systems of patients albeit more costly than allogeneic therapies. \n</p>\n<p>\n     CytoMed is pleased to announce ICH Capital has agreed to invest up to US$500,000 for a 10.0% post-money stake in LongevityBank. Founded in 2001, ICH Capital is a well-known Singapore-based investment firm that provides cross-border wealth and asset management solutions for ultra-high net worth individuals and institutions across Asia-Pacific. \n</p>\n<p>\n     ICH Capital's Chairman Vincent Toe remarked \"Through LongevityBank, a strategic new subsidiary of CytoMed, ICH Capital gains relevant exposure into the end-to-end solutions of cell banking and autologous cell therapies. We believe this is the future of healthcare and LongevityBank is well positioned to be a leading player in Southeast Asia.\" \n</p>\n<p>\n     To capitalize on rapidly growing medical tourism in low cost-Southeast Asia and to prepare for positive regulatory changes, we are exploring with potential investors and authorities on setting up a joint venture cancer care centre offering both conventional cancer treatments and the new cell therapy modalities. Interested investors are welcome to contact us. We are also exploring the possibility of offering free access to our clinical trial participation to our shareholders and their spouses who have no alternative treatment options, subject to relevant doctors' approval. \n</p>\n<p>\n     Other updates \n</p>\n<p>\n     China's State Council Decree No. 818 released on October 10, 2025 establishes a definitive regulatory pathway from clinical research to reimbursable clinical application for cell therapies. The key distinction is that these therapies are to be regulated as biotechnological medical procedures under a 'clinical study to clinical application' pathway within the health system, rather than following the traditional drug registration process. \"This approach creates a mechanism for approved therapies to be incorporated into medical service pricing systems, providing a tailored and timely opportunity for CytoMed to introduce its patented, off-the-shelf allogeneic gamma delta T cell platform to China.\" stated Peter Choo the Chairman of CytoMed. \n</p>\n<p>\n     CytoMed is in discussion with multiple Chinese companies to jointly develop and commercialize a new method using non-cellular cytokines to manufacture donor-derived unmodified allogeneic gamma delta T cells in China at low cost. \n</p>\n<p>\n     CytoMed's proprietary gamma delta T cell technology and the associated chimeric antigen receptor gamma delta T cell (CAR-&lt;GAMMA&gt; T cell) technology have been granted a patent by the <a href=\"https://laohu8.com/S/688128\">China National</a> Intellectual Property Administration (CNIPA). The Company is conducting an Investigational New Drug (IND) first-in-human Phase I clinical trial in Singapore at the National University Hospital Singapore. \n</p>\n<p>\n     CytoMed <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Limited (CytoMed) \n</p>\n<p>\n     Incorporated in 2018, CytoMed was spun off from the Agency for Science, Technology and Research (A*STAR), Singapore's leading research and development agency in the public sector. CytoMed is a clinical stage biopharmaceutical company focused on harnessing its licensed proprietary technologies, namely gamma delta T cell and iPSC-derived gamma delta Natural Killer T cell, to create novel cell-based allogeneic immunotherapies for the treatment of various human cancers. The development of novel technologies has been inspired by the clinical success of existing CAR-T therapies in treating haematological malignancies, as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumours. For more information, please visit www.cytomed.sg and follow us on Twitter (\"X\") @CytomedSG, on LinkedIn, and <a href=\"https://laohu8.com/S/META\">Facebook</a>. \n</p>\n<p>\n     Forward Looking Statements \n</p>\n<p>\n     This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as \"may, \"will, \"intend,\" \"should,\" \"believe,\" \"expect,\" \"anticipate,\" \"project,\" \"estimate\" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's plans to develop and commercialize its product candidates; the initiation, timing, progress and results of the Company's current and future pre-clinical studies and clinical trials and the Company's R&amp;D programs; the Company's estimates regarding expenses, future revenue, capital requirements and needs for additional financing; the Company's ability to successfully acquire or obtain licenses for additional product candidates on reasonable terms; the Company's ability to establish and maintain collaborations and/or obtain additional funding and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company's filings with the SEC, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward--looking statements to reflect events or circumstances that arise after the date hereof. \n</p>\n<p>\n     Contact: \n</p>\n<p>\n     CytoMed Therapeutics Limited \n</p>\n<p>\n     enquiry@cytomed.sg \n</p>\n<p>\n     Attention : Evelyn Tan, Chief Corporate Officer \n</p>\n<pre style=\"white-space: pre\">\n \n \n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 06, 2025 08:00 ET (13:00 GMT)\n</p>\n</font>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Press Release: CytoMed Therapeutics Secures Non-Dilutive Investment for Subsidiary LongevityBank from ICH Capital and Updates on New China Strategy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPress Release: CytoMed Therapeutics Secures Non-Dilutive Investment for Subsidiary LongevityBank from ICH Capital and Updates on New China Strategy\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-11-06 21:00</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     SINGAPORE, Nov. 06, 2025 (GLOBE NEWSWIRE) -- <a href=\"https://laohu8.com/S/GDTC\">CytoMed Therapeutics Limited</a> (NASDAQ: GDTC) (\"CytoMed\" or \"Company\"), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary technologies to develop novel affordable donor-derived cell-based immunotherapies for the treatment of a broad range of cancers, including both blood and solid tumours, announced today that it secures non-dilutive investment for its subsidiary, LongevityBank Pte Ltd (\"LongevityBank\") from ICH Capital Pte Ltd (\"ICH Capital\"). \n</p>\n<p>\n     Following the announcement dated August 28, 2025, the strategic vision is for LongevityBank to focus on autologous (using one's own blood, cells and/or tissues) therapies leveraging its personalized cellular banking services while parent company, CytoMed focuses on donor blood-derived allogeneic (using donated blood, cells and/or tissues) therapies which already has an approved IND Phase I clinical trial ongoing in Singapore and a Phase II Investigator-Initiated Trial (IIT) in India. Allogeneic therapies have the advantage of treatment speed, accessibility and cost-effectiveness. Autologous therapies are less likely to be rejected by one's own immune system and are better tolerated with higher acceptance level by the immune systems of patients albeit more costly than allogeneic therapies. \n</p>\n<p>\n     CytoMed is pleased to announce ICH Capital has agreed to invest up to US$500,000 for a 10.0% post-money stake in LongevityBank. Founded in 2001, ICH Capital is a well-known Singapore-based investment firm that provides cross-border wealth and asset management solutions for ultra-high net worth individuals and institutions across Asia-Pacific. \n</p>\n<p>\n     ICH Capital's Chairman Vincent Toe remarked \"Through LongevityBank, a strategic new subsidiary of CytoMed, ICH Capital gains relevant exposure into the end-to-end solutions of cell banking and autologous cell therapies. We believe this is the future of healthcare and LongevityBank is well positioned to be a leading player in Southeast Asia.\" \n</p>\n<p>\n     To capitalize on rapidly growing medical tourism in low cost-Southeast Asia and to prepare for positive regulatory changes, we are exploring with potential investors and authorities on setting up a joint venture cancer care centre offering both conventional cancer treatments and the new cell therapy modalities. Interested investors are welcome to contact us. We are also exploring the possibility of offering free access to our clinical trial participation to our shareholders and their spouses who have no alternative treatment options, subject to relevant doctors' approval. \n</p>\n<p>\n     Other updates \n</p>\n<p>\n     China's State Council Decree No. 818 released on October 10, 2025 establishes a definitive regulatory pathway from clinical research to reimbursable clinical application for cell therapies. The key distinction is that these therapies are to be regulated as biotechnological medical procedures under a 'clinical study to clinical application' pathway within the health system, rather than following the traditional drug registration process. \"This approach creates a mechanism for approved therapies to be incorporated into medical service pricing systems, providing a tailored and timely opportunity for CytoMed to introduce its patented, off-the-shelf allogeneic gamma delta T cell platform to China.\" stated Peter Choo the Chairman of CytoMed. \n</p>\n<p>\n     CytoMed is in discussion with multiple Chinese companies to jointly develop and commercialize a new method using non-cellular cytokines to manufacture donor-derived unmodified allogeneic gamma delta T cells in China at low cost. \n</p>\n<p>\n     CytoMed's proprietary gamma delta T cell technology and the associated chimeric antigen receptor gamma delta T cell (CAR-&lt;GAMMA&gt; T cell) technology have been granted a patent by the <a href=\"https://laohu8.com/S/688128\">China National</a> Intellectual Property Administration (CNIPA). The Company is conducting an Investigational New Drug (IND) first-in-human Phase I clinical trial in Singapore at the National University Hospital Singapore. \n</p>\n<p>\n     CytoMed <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Limited (CytoMed) \n</p>\n<p>\n     Incorporated in 2018, CytoMed was spun off from the Agency for Science, Technology and Research (A*STAR), Singapore's leading research and development agency in the public sector. CytoMed is a clinical stage biopharmaceutical company focused on harnessing its licensed proprietary technologies, namely gamma delta T cell and iPSC-derived gamma delta Natural Killer T cell, to create novel cell-based allogeneic immunotherapies for the treatment of various human cancers. The development of novel technologies has been inspired by the clinical success of existing CAR-T therapies in treating haematological malignancies, as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumours. For more information, please visit www.cytomed.sg and follow us on Twitter (\"X\") @CytomedSG, on LinkedIn, and <a href=\"https://laohu8.com/S/META\">Facebook</a>. \n</p>\n<p>\n     Forward Looking Statements \n</p>\n<p>\n     This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as \"may, \"will, \"intend,\" \"should,\" \"believe,\" \"expect,\" \"anticipate,\" \"project,\" \"estimate\" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's plans to develop and commercialize its product candidates; the initiation, timing, progress and results of the Company's current and future pre-clinical studies and clinical trials and the Company's R&amp;D programs; the Company's estimates regarding expenses, future revenue, capital requirements and needs for additional financing; the Company's ability to successfully acquire or obtain licenses for additional product candidates on reasonable terms; the Company's ability to establish and maintain collaborations and/or obtain additional funding and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company's filings with the SEC, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward--looking statements to reflect events or circumstances that arise after the date hereof. \n</p>\n<p>\n     Contact: \n</p>\n<p>\n     CytoMed Therapeutics Limited \n</p>\n<p>\n     enquiry@cytomed.sg \n</p>\n<p>\n     Attention : Evelyn Tan, Chief Corporate Officer \n</p>\n<pre style=\"white-space: pre\">\n \n \n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 06, 2025 08:00 ET (13:00 GMT)\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4139":"生物科技","GDTC":"CytoMed Therapeutics Limited","BK4007":"制药","LENZ":"Therapeutics","BK4539":"次新股"},"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2581093986","content_text":"SINGAPORE, Nov. 06, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (\"CytoMed\" or \"Company\"), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary technologies to develop novel affordable donor-derived cell-based immunotherapies for the treatment of a broad range of cancers, including both blood and solid tumours, announced today that it secures non-dilutive investment for its subsidiary, LongevityBank Pte Ltd (\"LongevityBank\") from ICH Capital Pte Ltd (\"ICH Capital\"). \n\n\n     Following the announcement dated August 28, 2025, the strategic vision is for LongevityBank to focus on autologous (using one's own blood, cells and/or tissues) therapies leveraging its personalized cellular banking services while parent company, CytoMed focuses on donor blood-derived allogeneic (using donated blood, cells and/or tissues) therapies which already has an approved IND Phase I clinical trial ongoing in Singapore and a Phase II Investigator-Initiated Trial (IIT) in India. Allogeneic therapies have the advantage of treatment speed, accessibility and cost-effectiveness. Autologous therapies are less likely to be rejected by one's own immune system and are better tolerated with higher acceptance level by the immune systems of patients albeit more costly than allogeneic therapies. \n\n\n     CytoMed is pleased to announce ICH Capital has agreed to invest up to US$500,000 for a 10.0% post-money stake in LongevityBank. Founded in 2001, ICH Capital is a well-known Singapore-based investment firm that provides cross-border wealth and asset management solutions for ultra-high net worth individuals and institutions across Asia-Pacific. \n\n\n     ICH Capital's Chairman Vincent Toe remarked \"Through LongevityBank, a strategic new subsidiary of CytoMed, ICH Capital gains relevant exposure into the end-to-end solutions of cell banking and autologous cell therapies. We believe this is the future of healthcare and LongevityBank is well positioned to be a leading player in Southeast Asia.\" \n\n\n     To capitalize on rapidly growing medical tourism in low cost-Southeast Asia and to prepare for positive regulatory changes, we are exploring with potential investors and authorities on setting up a joint venture cancer care centre offering both conventional cancer treatments and the new cell therapy modalities. Interested investors are welcome to contact us. We are also exploring the possibility of offering free access to our clinical trial participation to our shareholders and their spouses who have no alternative treatment options, subject to relevant doctors' approval. \n\n\n     Other updates \n\n\n     China's State Council Decree No. 818 released on October 10, 2025 establishes a definitive regulatory pathway from clinical research to reimbursable clinical application for cell therapies. The key distinction is that these therapies are to be regulated as biotechnological medical procedures under a 'clinical study to clinical application' pathway within the health system, rather than following the traditional drug registration process. \"This approach creates a mechanism for approved therapies to be incorporated into medical service pricing systems, providing a tailored and timely opportunity for CytoMed to introduce its patented, off-the-shelf allogeneic gamma delta T cell platform to China.\" stated Peter Choo the Chairman of CytoMed. \n\n\n     CytoMed is in discussion with multiple Chinese companies to jointly develop and commercialize a new method using non-cellular cytokines to manufacture donor-derived unmodified allogeneic gamma delta T cells in China at low cost. \n\n\n     CytoMed's proprietary gamma delta T cell technology and the associated chimeric antigen receptor gamma delta T cell (CAR-<GAMMA> T cell) technology have been granted a patent by the China National Intellectual Property Administration (CNIPA). The Company is conducting an Investigational New Drug (IND) first-in-human Phase I clinical trial in Singapore at the National University Hospital Singapore. \n\n\n     CytoMed Therapeutics Limited (CytoMed) \n\n\n     Incorporated in 2018, CytoMed was spun off from the Agency for Science, Technology and Research (A*STAR), Singapore's leading research and development agency in the public sector. CytoMed is a clinical stage biopharmaceutical company focused on harnessing its licensed proprietary technologies, namely gamma delta T cell and iPSC-derived gamma delta Natural Killer T cell, to create novel cell-based allogeneic immunotherapies for the treatment of various human cancers. The development of novel technologies has been inspired by the clinical success of existing CAR-T therapies in treating haematological malignancies, as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumours. For more information, please visit www.cytomed.sg and follow us on Twitter (\"X\") @CytomedSG, on LinkedIn, and Facebook. \n\n\n     Forward Looking Statements \n\n\n     This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as \"may, \"will, \"intend,\" \"should,\" \"believe,\" \"expect,\" \"anticipate,\" \"project,\" \"estimate\" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's plans to develop and commercialize its product candidates; the initiation, timing, progress and results of the Company's current and future pre-clinical studies and clinical trials and the Company's R&D programs; the Company's estimates regarding expenses, future revenue, capital requirements and needs for additional financing; the Company's ability to successfully acquire or obtain licenses for additional product candidates on reasonable terms; the Company's ability to establish and maintain collaborations and/or obtain additional funding and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company's filings with the SEC, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward--looking statements to reflect events or circumstances that arise after the date hereof. \n\n\n     Contact: \n\n\n     CytoMed Therapeutics Limited \n\n\n     enquiry@cytomed.sg \n\n\n     Attention : Evelyn Tan, Chief Corporate Officer \n\n\n \n \n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 06, 2025 08:00 ET (13:00 GMT)","news_type":1,"symbols_score_info":{"LENZ":1.5,"GDTC":1}},"isVote":1,"tweetType":1,"viewCount":651,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":503041892630576,"gmtCreate":1763821467150,"gmtModify":1763853495401,"author":{"id":"3581654847570147","authorId":"3581654847570147","name":"GreenArt","avatar":"https://static.tigerbbs.com/4da854bffe68ea665dbcd4c6e26e6e53","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581654847570147","idStr":"3581654847570147"},"themes":[],"title":"","htmlText":"The benefits of bottom-up ensures you that the company is strong and have good potential for \"Investing\". The big picture is not so controllable IMHO. Especially recent geo political environment changes fast. But it is best if we have the discipline to spread out the risk &amp; be patient.","listText":"The benefits of bottom-up ensures you that the company is strong and have good potential for \"Investing\". The big picture is not so controllable IMHO. Especially recent geo political environment changes fast. But it is best if we have the discipline to spread out the risk &amp; be patient.","text":"The benefits of bottom-up ensures you that the company is strong and have good potential for \"Investing\". The big picture is not so controllable IMHO. Especially recent geo political environment changes fast. But it is best if we have the discipline to spread out the risk & be patient.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/503041892630576","isVote":1,"tweetType":1,"viewCount":1241,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":522739624801392,"gmtCreate":1768657211108,"gmtModify":1768657214781,"author":{"id":"3581654847570147","authorId":"3581654847570147","name":"GreenArt","avatar":"https://static.tigerbbs.com/4da854bffe68ea665dbcd4c6e26e6e53","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581654847570147","authorIdStr":"3581654847570147"},"themes":[],"title":"","htmlText":"Hope to see V recovery next week. 😆","listText":"Hope to see V recovery next week. 😆","text":"Hope to see V recovery next week. 😆","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":133,"commentSize":3,"repostSize":73,"link":"https://ttm.financial/post/522739624801392","isVote":1,"tweetType":1,"viewCount":6614,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":516802301149392,"gmtCreate":1767195431316,"gmtModify":1767195434820,"author":{"id":"3581654847570147","authorId":"3581654847570147","name":"GreenArt","avatar":"https://static.tigerbbs.com/4da854bffe68ea665dbcd4c6e26e6e53","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581654847570147","authorIdStr":"3581654847570147"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/ONDS\">$Ondas Holdings Inc.(ONDS)$ </a> Take profits for new year&nbsp;meal.&nbsp;","listText":"<a href=\"https://ttm.financial/S/ONDS\">$Ondas Holdings Inc.(ONDS)$ </a> Take profits for new year&nbsp;meal.&nbsp;","text":"$Ondas Holdings Inc.(ONDS)$ Take profits for new year meal.","images":[{"img":"https://community-static.tradeup.com/news/95307d43d8d6eaa95db1e5cddb0e24d2","width":"876","height":"1720"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/516802301149392","isVote":1,"tweetType":1,"viewCount":410,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":516802243396408,"gmtCreate":1767195344095,"gmtModify":1767195347720,"author":{"id":"3581654847570147","authorId":"3581654847570147","name":"GreenArt","avatar":"https://static.tigerbbs.com/4da854bffe68ea665dbcd4c6e26e6e53","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581654847570147","authorIdStr":"3581654847570147"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/TSM\">$Taiwan Semiconductor Manufacturing(TSM)$ </a> profiting from volatility&nbsp;","listText":"<a href=\"https://ttm.financial/S/TSM\">$Taiwan Semiconductor Manufacturing(TSM)$ </a> profiting from volatility&nbsp;","text":"$Taiwan Semiconductor Manufacturing(TSM)$ profiting from volatility","images":[{"img":"https://community-static.tradeup.com/news/2bd95b552791c4725a6c92cd572889a9","width":"876","height":"1720"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/516802243396408","isVote":1,"tweetType":1,"viewCount":425,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":506499938161392,"gmtCreate":1764678922276,"gmtModify":1764678925600,"author":{"id":"3581654847570147","authorId":"3581654847570147","name":"GreenArt","avatar":"https://static.tigerbbs.com/4da854bffe68ea665dbcd4c6e26e6e53","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581654847570147","authorIdStr":"3581654847570147"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/ONDS\">$Ondas Holdings Inc.(ONDS)$ </a> Sold partial. Brought back after it pulled back again. Waiting for next trade.","listText":"<a href=\"https://ttm.financial/S/ONDS\">$Ondas Holdings Inc.(ONDS)$ </a> Sold partial. Brought back after it pulled back again. Waiting for next trade.","text":"$Ondas Holdings Inc.(ONDS)$ Sold partial. Brought back after it pulled back again. Waiting for next trade.","images":[{"img":"https://community-static.tradeup.com/news/417c621f7d43ff3e2f7f5557bf0eefd8","width":"876","height":"1720"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/506499938161392","isVote":1,"tweetType":1,"viewCount":648,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":125184556,"gmtCreate":1624664429575,"gmtModify":1703842954117,"author":{"id":"3581654847570147","authorId":"3581654847570147","name":"GreenArt","avatar":"https://static.tigerbbs.com/4da854bffe68ea665dbcd4c6e26e6e53","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581654847570147","authorIdStr":"3581654847570147"},"themes":[],"htmlText":"Kindly comment &amp; like. Thank you!","listText":"Kindly comment &amp; like. Thank you!","text":"Kindly comment & like. Thank you!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":5,"repostSize":0,"link":"https://ttm.financial/post/125184556","repostId":"1177764085","repostType":4,"isVote":1,"tweetType":1,"viewCount":2453,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":529188267828240,"gmtCreate":1770218533034,"gmtModify":1770218538260,"author":{"id":"3581654847570147","authorId":"3581654847570147","name":"GreenArt","avatar":"https://static.tigerbbs.com/4da854bffe68ea665dbcd4c6e26e6e53","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581654847570147","authorIdStr":"3581654847570147"},"themes":[],"title":"","htmlText":"Monitoring for scooping.&nbsp;","listText":"Monitoring for scooping.&nbsp;","text":"Monitoring for scooping.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/529188267828240","repostId":"528823073592016","repostType":1,"repost":{"id":528823073592016,"gmtCreate":1770129362432,"gmtModify":1770129494610,"author":{"id":"4125545119825582","authorId":"4125545119825582","name":"HRHRHRHR","avatar":"https://community-static.tradeup.com/news/f72f7c8c7a3f167c0f03f6041d1ff44f","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4125545119825582","authorIdStr":"4125545119825582"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/MSFT\">$Microsoft(MSFT)$&nbsp;</a> $416 now... back to Year 2024 prices.. Imagine holding this stock till Jan 2026 and getting nothing in return 😅 So tempted to add MFST but gut feeling says geopolitics will cause the stock to fall much lower.&nbsp;","listText":"<a href=\"https://ttm.financial/S/MSFT\">$Microsoft(MSFT)$&nbsp;</a> $416 now... back to Year 2024 prices.. Imagine holding this stock till Jan 2026 and getting nothing in return 😅 So tempted to add MFST but gut feeling says geopolitics will cause the stock to fall much lower.&nbsp;","text":"$Microsoft(MSFT)$ $416 now... back to Year 2024 prices.. Imagine holding this stock till Jan 2026 and getting nothing in return 😅 So tempted to add MFST but gut feeling says geopolitics will cause the stock to fall much lower.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/528823073592016","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":14,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":520553996792928,"gmtCreate":1768136656124,"gmtModify":1768136660064,"author":{"id":"3581654847570147","authorId":"3581654847570147","name":"GreenArt","avatar":"https://static.tigerbbs.com/4da854bffe68ea665dbcd4c6e26e6e53","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581654847570147","authorIdStr":"3581654847570147"},"themes":[],"title":"","htmlText":"Add to long...&nbsp;","listText":"Add to long...&nbsp;","text":"Add to long...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":2,"link":"https://ttm.financial/post/520553996792928","repostId":"519972794053328","repostType":1,"repost":{"id":519972794053328,"gmtCreate":1767981669861,"gmtModify":1768072802290,"author":{"id":"4171900329979952","authorId":"4171900329979952","name":"Barcode","avatar":"https://community-static.tradeup.com/news/6688d8fb4c2a255e3b901e79755e56df","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4171900329979952","authorIdStr":"4171900329979952"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/TSLA\">$Tesla Motors(TSLA)$</a>&nbsp;<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$&nbsp;</a>&nbsp;<a href=\"https://ttm.financial/S/INTC\">$Intel(INTC)$&nbsp;</a> 09Jan26 ET 🇺🇸 | 10Jan26 NZT 🇳🇿 🚀 $TSLA +$10 now&nbsp; ⏪ Was -$8 vs pre-market earlier ⬆️ Now +$16 off the lows 📆 We’re sitting +$5 on the week — even though $NVDA’s AI autonomy stack was supposed to lead first — even though robotaxi fleets still run with safety drivers and L4 constraints — even though Elon Musk's political noise on X keeps feeding headline volatility 📈 Price before narratives. Always. 🗓️ Key dates now on the radar • 13 Jan hearing on lifting the 2,500 AV cap • 14 Jan Supreme Court opinion on Trump tariffs ⚡ Next week is shaping up volatile for $TSLA 🤖🦾🔋 🚘🤖 ʜᴀᴘᴘʏ TESLA ᴛʀᴀᴅɪɴɢ","listText":"<a href=\"https://ttm.financial/S/TSLA\">$Tesla Motors(TSLA)$</a>&nbsp;<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$&nbsp;</a>&nbsp;<a href=\"https://ttm.financial/S/INTC\">$Intel(INTC)$&nbsp;</a> 09Jan26 ET 🇺🇸 | 10Jan26 NZT 🇳🇿 🚀 $TSLA +$10 now&nbsp; ⏪ Was -$8 vs pre-market earlier ⬆️ Now +$16 off the lows 📆 We’re sitting +$5 on the week — even though $NVDA’s AI autonomy stack was supposed to lead first — even though robotaxi fleets still run with safety drivers and L4 constraints — even though Elon Musk's political noise on X keeps feeding headline volatility 📈 Price before narratives. Always. 🗓️ Key dates now on the radar • 13 Jan hearing on lifting the 2,500 AV cap • 14 Jan Supreme Court opinion on Trump tariffs ⚡ Next week is shaping up volatile for $TSLA 🤖🦾🔋 🚘🤖 ʜᴀᴘᴘʏ TESLA ᴛʀᴀᴅɪɴɢ","text":"$Tesla Motors(TSLA)$ $NVIDIA(NVDA)$ $Intel(INTC)$ 09Jan26 ET 🇺🇸 | 10Jan26 NZT 🇳🇿 🚀 $TSLA +$10 now ⏪ Was -$8 vs pre-market earlier ⬆️ Now +$16 off the lows 📆 We’re sitting +$5 on the week — even though $NVDA’s AI autonomy stack was supposed to lead first — even though robotaxi fleets still run with safety drivers and L4 constraints — even though Elon Musk's political noise on X keeps feeding headline volatility 📈 Price before narratives. Always. 🗓️ Key dates now on the radar • 13 Jan hearing on lifting the 2,500 AV cap • 14 Jan Supreme Court opinion on Trump tariffs ⚡ Next week is shaping up volatile for $TSLA 🤖🦾🔋 🚘🤖 ʜᴀᴘᴘʏ TESLA ᴛʀᴀᴅɪɴɢ","images":[{"img":"https://community-static.tradeup.com/news/ac7fbf6c449ce9ccd9dd9f6db80118bf","width":"1138","height":"1943"},{"img":"https://community-static.tradeup.com/news/7a0756e636ba01c7e482848977770a2b","width":"1472","height":"1202"},{"img":"https://community-static.tradeup.com/news/9f080f09696443332ccd5e3d300b778c","width":"1472","height":"828"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/519972794053328","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":3,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":278,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":494321905418816,"gmtCreate":1761710125001,"gmtModify":1761710129671,"author":{"id":"3581654847570147","authorId":"3581654847570147","name":"GreenArt","avatar":"https://static.tigerbbs.com/4da854bffe68ea665dbcd4c6e26e6e53","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581654847570147","authorIdStr":"3581654847570147"},"themes":[],"htmlText":"Brilliant move by NVDA CEO, investing into multiple &amp; different&nbsp; \"supply chain\" from Intel to Nokia etc. The whole eco system intertwined and grow together, securing from fab to end user. Mitigating potential loss/risk in China market too. I will vote him CEO of the year of there's one. 😆","listText":"Brilliant move by NVDA CEO, investing into multiple &amp; different&nbsp; \"supply chain\" from Intel to Nokia etc. The whole eco system intertwined and grow together, securing from fab to end user. Mitigating potential loss/risk in China market too. I will vote him CEO of the year of there's one. 😆","text":"Brilliant move by NVDA CEO, investing into multiple & different \"supply chain\" from Intel to Nokia etc. The whole eco system intertwined and grow together, securing from fab to end user. Mitigating potential loss/risk in China market too. I will vote him CEO of the year of there's one. 😆","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":1,"link":"https://ttm.financial/post/494321905418816","isVote":1,"tweetType":1,"viewCount":1199,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":494141832061888,"gmtCreate":1761666269736,"gmtModify":1761666274408,"author":{"id":"3581654847570147","authorId":"3581654847570147","name":"GreenArt","avatar":"https://static.tigerbbs.com/4da854bffe68ea665dbcd4c6e26e6e53","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581654847570147","authorIdStr":"3581654847570147"},"themes":[],"htmlText":"I am using my gmail, google search, my cloud storage, Microsoft office. So, Google &amp; Microsoft is my bet to go up. 🚀","listText":"I am using my gmail, google search, my cloud storage, Microsoft office. So, Google &amp; Microsoft is my bet to go up. 🚀","text":"I am using my gmail, google search, my cloud storage, Microsoft office. So, Google & Microsoft is my bet to go up. 🚀","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/494141832061888","isVote":1,"tweetType":1,"viewCount":1289,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":127261748,"gmtCreate":1624851359384,"gmtModify":1703846206535,"author":{"id":"3581654847570147","authorId":"3581654847570147","name":"GreenArt","avatar":"https://static.tigerbbs.com/4da854bffe68ea665dbcd4c6e26e6e53","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581654847570147","authorIdStr":"3581654847570147"},"themes":[],"htmlText":"? ?Like &amp; comment.&nbsp;","listText":"? ?Like &amp; comment.&nbsp;","text":"? ?Like & comment.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/127261748","repostId":"1161283536","repostType":4,"repost":{"id":"1161283536","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1624850034,"share":"https://ttm.financial/m/news/1161283536?lang=en_US&edition=fundamental","pubTime":"2021-06-28 11:13","market":"hk","language":"en","title":"The Hong Kong Stock Exchange will resume trading at 1:30 p.m., as the rainstorm signal changes.","url":"https://stock-news.laohu8.com/highlight/detail?id=1161283536","media":"Tiger Newspress","summary":"Hong Kong stocks will resume trading Monday afternoon, after the city’s weather observatory lowered ","content":"<p>Hong Kong stocks will resume trading Monday afternoon, after the city’s weather observatory lowered its rainstorm warning that had earlier prompted the cancellation of the morning session.</p>\n<p>The Hong Kong Observatory lowered the rainstorm warning to red from black shortly after 11 a.m. local time, meaning stock trading will begin at 1:30 p.m. in accordance with Hong Kong Exchanges and Clearing Ltd.’s rules. The bourse operator had earlier canceled morning trading of bothsecuritiesand derivatives markets, including Stock Connect due to the black rain warning.</p>\n<p>Earlier the city’s education bureau suspended classes across Hong Kong due to the severe weather conditions. The government will resume vaccination after lowering the rainstorm warning.</p>\n<p>Morning trading in the city was lastcanceledin October last year, when tropical storm Nangka prompted authorities to shutter businesses and close schools. Average dailyturnoverin Hong Kong this year stands at around HK$188 billion ($24.2 billion), according to data compiled by Bloomberg.</p>\n<p>When the market reopens in the afternoon, “there will still be plenty of time to digest weekend news and A-share movements,” said Steven Leung, executive director of UoB Kay Hian (Hong Kong) Ltd. “Markets have been relatively stable in both Hong Kong and A shares lately.”</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The Hong Kong Stock Exchange will resume trading at 1:30 p.m., as the rainstorm signal changes.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe Hong Kong Stock Exchange will resume trading at 1:30 p.m., as the rainstorm signal changes.\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-28 11:13</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hong Kong stocks will resume trading Monday afternoon, after the city’s weather observatory lowered its rainstorm warning that had earlier prompted the cancellation of the morning session.</p>\n<p>The Hong Kong Observatory lowered the rainstorm warning to red from black shortly after 11 a.m. local time, meaning stock trading will begin at 1:30 p.m. in accordance with Hong Kong Exchanges and Clearing Ltd.’s rules. The bourse operator had earlier canceled morning trading of bothsecuritiesand derivatives markets, including Stock Connect due to the black rain warning.</p>\n<p>Earlier the city’s education bureau suspended classes across Hong Kong due to the severe weather conditions. The government will resume vaccination after lowering the rainstorm warning.</p>\n<p>Morning trading in the city was lastcanceledin October last year, when tropical storm Nangka prompted authorities to shutter businesses and close schools. Average dailyturnoverin Hong Kong this year stands at around HK$188 billion ($24.2 billion), according to data compiled by Bloomberg.</p>\n<p>When the market reopens in the afternoon, “there will still be plenty of time to digest weekend news and A-share movements,” said Steven Leung, executive director of UoB Kay Hian (Hong Kong) Ltd. “Markets have been relatively stable in both Hong Kong and A shares lately.”</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HSI":"恒生指数"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1161283536","content_text":"Hong Kong stocks will resume trading Monday afternoon, after the city’s weather observatory lowered its rainstorm warning that had earlier prompted the cancellation of the morning session.\nThe Hong Kong Observatory lowered the rainstorm warning to red from black shortly after 11 a.m. local time, meaning stock trading will begin at 1:30 p.m. in accordance with Hong Kong Exchanges and Clearing Ltd.’s rules. The bourse operator had earlier canceled morning trading of bothsecuritiesand derivatives markets, including Stock Connect due to the black rain warning.\nEarlier the city’s education bureau suspended classes across Hong Kong due to the severe weather conditions. The government will resume vaccination after lowering the rainstorm warning.\nMorning trading in the city was lastcanceledin October last year, when tropical storm Nangka prompted authorities to shutter businesses and close schools. Average dailyturnoverin Hong Kong this year stands at around HK$188 billion ($24.2 billion), according to data compiled by Bloomberg.\nWhen the market reopens in the afternoon, “there will still be plenty of time to digest weekend news and A-share movements,” said Steven Leung, executive director of UoB Kay Hian (Hong Kong) Ltd. “Markets have been relatively stable in both Hong Kong and A shares lately.”","news_type":1,"symbols_score_info":{"HSI":0.9}},"isVote":1,"tweetType":1,"viewCount":2605,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}